By Cristina Gallardo
Grifols and Brookfield said they aren't in takeover talks, after a media report indicated the investment company had resumed discussions with the Grifols family--which controls the Spanish pharmaceutical company--about a possible deal.
"Brookfield is not, and has not been, in discussions with the company's board of directors with respect to a potential transaction," Brookfield said.
The investor said it maintains a general dialogue with Grifols's reference shareholders, but said there is no update since it decided against making a bid for the company in November.
Grifols's board said separately that it "has no knowledge" of talks regarding another attempt by Brookfield to acquire the company.
The statements came after Spanish news website El Confidencial reported, citing unnamed sources, that Brookfield had resumed talks with the Grifols family over a possible deal.
Shares in Grifols traded 6% higher at 8.63 euros in European afternoon trading, paring back gains of as much as 15% earlier in the session, after both Grifols and Brookfield issued their statements.
Write to Cristina Gallardo at cristina.gallardo@wsj.com
(END) Dow Jones Newswires
April 02, 2025 08:47 ET (12:47 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.